blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3225632

EP3225632 - ANTIBODIES BINDING TO B7-H1, A NOVEL IMMUNOREGULATORY MOLECULE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.03.2021
Database last updated on 15.05.2024
FormerThe patent has been granted
Status updated on  03.04.2020
FormerGrant of patent is intended
Status updated on  18.03.2020
FormerExamination is in progress
Status updated on  19.04.2019
FormerRequest for examination was made
Status updated on  16.04.2019
FormerExamination is in progress
Status updated on  09.02.2019
FormerRequest for examination was made
Status updated on  01.09.2017
Most recent event   Tooltip30.04.2021Lapse of the patent in a contracting state
New state(s): GB		published on 02.06.2021  [2021/22]
Applicant(s)For all designated states
Mayo Foundation for Medical Education and Research
200 First Street S.W.
Rochester, MN 55905 / US
[2017/40]
Inventor(s)01 / CHEN, Lieping
2821 Char Lane, N.E.
Rochester, MN 55906 / US
 [2017/40]
Representative(s)Fish & Richardson P.C.
Highlight Business Towers
Mies-van-der-Rohe-Straße 8
80807 München / DE
[N/P]
Former [2020/19]Kunz, Herbert
Fish & Richardson P.C.
Highlight Business Towers
Mies-van-der-Rohe-Straße 8
80807 München / DE
Former [2017/40]Burda, Martin Robert
Fish & Richardson P.C.
HighLight Business Towers
Mies-van-der-Rohe-Straße 8
80807 München / DE
Application number, filing date17159364.330.11.2000
[2017/40]
Priority number, dateUS1999045129130.11.1999         Original published format: US 451291
US2000064910828.08.2000         Original published format: US 649108
[2017/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3225632
Date:04.10.2017
Language:EN
[2017/40]
Type: B1 Patent specification 
No.:EP3225632
Date:06.05.2020
Language:EN
[2020/19]
Search report(s)(Supplementary) European search report - dispatched on:EP17.07.2017
ClassificationIPC:C07K14/705, C07K16/28, C07K16/46
[2017/40]
CPC:
C07K14/47 (EP,US); C07K14/70532 (US); A61K39/39 (US);
C07K16/00 (US); C07K16/2827 (US); G01N33/502 (US);
G01N33/505 (US); A61K2035/124 (EP,US); A61K38/00 (EP,US);
C07K2317/24 (US); C07K2317/524 (US); C07K2317/526 (US);
C07K2317/76 (US); C07K2319/74 (US); G01N2333/70532 (US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2017/40]
TitleGerman:AN B7-H1, EIN NEUARTIGES IMMUNREGULIERENDES MOLEKÜL BINDENDE ANTIKÖRPER[2017/40]
English:ANTIBODIES BINDING TO B7-H1, A NOVEL IMMUNOREGULATORY MOLECULE[2017/40]
French:ANTICOPRS SE LIANT À LA NOUVELLE MOLÉCULE IMMUNORÉGULATRICE B7-H1[2017/40]
Examination procedure06.03.2017Examination requested  [2017/40]
06.03.2017Date on which the examining division has become responsible
04.04.2018Amendment by applicant (claims and/or description)
09.04.2019Observations by third parties
25.04.2019Despatch of a communication from the examining division (Time limit: M06)
05.11.2019Reply to a communication from the examining division
18.12.2019Observations by third parties
19.03.2020Communication of intention to grant the patent
31.03.2020Fee for grant paid
31.03.2020Fee for publishing/printing paid
31.03.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP00983821.0  / EP1234031
Opposition(s)09.02.2021No opposition filed within time limit [2021/15]
Fees paidRenewal fee
06.03.2017Renewal fee patent year 03
06.03.2017Renewal fee patent year 04
06.03.2017Renewal fee patent year 05
06.03.2017Renewal fee patent year 06
06.03.2017Renewal fee patent year 07
06.03.2017Renewal fee patent year 08
06.03.2017Renewal fee patent year 09
06.03.2017Renewal fee patent year 10
06.03.2017Renewal fee patent year 11
06.03.2017Renewal fee patent year 12
06.03.2017Renewal fee patent year 13
06.03.2017Renewal fee patent year 14
06.03.2017Renewal fee patent year 15
06.03.2017Renewal fee patent year 16
06.03.2017Renewal fee patent year 17
27.11.2017Renewal fee patent year 18
27.11.2018Renewal fee patent year 19
27.11.2019Renewal fee patent year 20
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT06.05.2020
DK06.05.2020
ES06.05.2020
FI06.05.2020
IT06.05.2020
SE06.05.2020
GR07.08.2020
PT07.09.2020
GB29.11.2020
IE30.11.2020
[2021/22]
Former [2021/20]AT06.05.2020
DK06.05.2020
ES06.05.2020
FI06.05.2020
IT06.05.2020
SE06.05.2020
GR07.08.2020
PT07.09.2020
IE30.11.2020
Former [2021/09]AT06.05.2020
DK06.05.2020
ES06.05.2020
FI06.05.2020
SE06.05.2020
GR07.08.2020
PT07.09.2020
IE30.11.2020
Former [2021/08]DK06.05.2020
ES06.05.2020
FI06.05.2020
SE06.05.2020
GR07.08.2020
PT07.09.2020
IE30.11.2020
Former [2020/50]FI06.05.2020
SE06.05.2020
GR07.08.2020
PT07.09.2020
Former [2020/48]FI06.05.2020
SE06.05.2020
PT07.09.2020
Documents cited:Search[E]WO0114556  (DANA FARBER CANCER INST INC [US]) [E] 1-11 * page 5, line 9 - line 11; claim 16 * * page 12, line 20 - page 13, line 2 * * page 36, line 18 - page 38, line 4; examples 8,9 *;
 [E]WO0114557  (DANA FARBER CANCER INST INC [US], et al) [E] 1-11 * examples 8-10 * * page 39, line 18 - line 22 * * page 43, line 11 - page 18 * * page 45, line 1 - line 8 * * page 50, line 23 - page 56, line 31 ** claim 8 *;
 [A]  - SWALLOW M M ET AL, "B7H, A NOVEL COSTIMULATORY HOMOLOG OF B7.1 AND B7.2 IS INDUCED BY TNFALPHA", INFECTION AND IMMUNITY, AMERICAN SOCIETY OF MICROBIOLOGY, WASHINGTON, DC, US, (199910), vol. 11, ISSN 0019-9567, pages 423 - 432, XP000971265 [A] 1-11 * the whole document *
 [A]  - HENRY J ET AL, "Structure and evolution of the extended B7 family", IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, (199906), vol. 20, no. 6, ISSN 0167-5699, pages 285 - 288, XP004169718 [A] 1-10 * page 1, column L; figure 1 * * page 3, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/S0167-5699(98)01418-2
 [AP]  - EMBL, Database accession no. AF177937, URL: EBI, XP002269036 [AP] 1-11 * abstract *
 [P]  - EMBL, Database accession no. Q9NZQ7, URL: EBI, XP002269037 [P] * abstract *
 [AP]  - EMBL, Database accession no. Q9EP73, URL: EBI, XP002269038 [AP] 1-11 * abstract *
by applicantEP0125023
 EP0171496
 EP0173494
 WO8601533
 EP0184187
 US4642334
 US4816567
 US5225539
    - KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 5873 - 5877
    - ALTSCHUL ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410
    - ALTSCHUL ET AL., NUCLEIC ACIDS RES., (1997), vol. 25, pages 3389 - 3402
    - Current Protocols in Molecular Biology, JOHN WILEY & SONS, (1991), pages 6.3.1 - 6.3.6
    - CRISTIANO ET AL., J. MOL. MED., (1995), vol. 73, page 479
    - THOMPSON ET AL., MOL. CELL. BIOL., (1992), vol. 12, pages 1043 - 1053
    - TODD ET AL., J. EXP. MED., (1993), vol. 177, pages 1663 - 1674
    - PENIX ET AL., J. EXP. MED., (1993), vol. 178, pages 1483 - 1496
    - BROUGHTON, CURR. OPIN. CHEM. BIOL., (1997), vol. 1, pages 392 - 398
    - BETTER ET AL., SCIENCE, (1988), vol. 240, pages 1041 - 43
    - LIU ET AL., J. IMMUNOL., (1987), vol. 139, pages 3521 - 26
    - SUN ET AL., PNAS, (1987), vol. 84, pages 214 - 18
    - NISHIMURA ET AL., CANC. RES., (1987), vol. 47, pages 999 - 1005
    - WOOD ET AL., NATURE, (1985), vol. 314, pages 446 - 49
    - SHAW ET AL., J. NATL. CANCER INST., (1988), vol. 80, pages 1553 - 59
    - MORRISON, SCIENCE, (1985), vol. 229, pages 1202 - 07
    - OI ET AL., BIOTECHNIQUES, (1986), vol. 4, page 214
    - JONES ET AL., NATURE, (1986), vol. 321, pages 552 - 25
    - VEROEYAN ET AL., SCIENCE, (1988), vol. 239, page 1534
    - BEIDLER ET AL., J. IMMUNOL., (1988), vol. 141, pages 4053 - 60
    - COLIGAN ET AL., Current Protocols In Immunology, WILEY INTERSCIENCE, (1991), pages 2.8 - 2.10
    - DONG ET AL., NATURE MED., (1999), vol. 5, pages 1365 - 1369
    - CHEN ET AL., J. EXP. MED., (1994), vol. 179, pages 523 - 532
    - LI ET AL., J. EXP. MED., (1996), vol. 183, pages 639 - 644
    - FARGEAS, C.A. ET AL., J. EXP. MED., (1995), vol. 182, pages 667 - 675
    - BAJORATH, J. ET AL., PROTEIN SCI., (1994), vol. 3, pages 2148 - 50
    - LINSLEY, P.S. ET AL., IMMUNITY, (1994), vol. 1, pages 793 - 801
    - INABA, K. ET AL., J. EXP. MED., (1994), vol. 180, pages 1849 - 60
    - FREEMAN, G. J. ET AL., IMMUNITY, (1995), vol. 2, pages 523 - 532
    - MARRACK; KAPPLER, J. IMMUNOL., (1975), vol. 114, pages 1116 - 1125
    - ROMANO ET AL., PROC. NATL. ACAD. SCI. USA, (1975), vol. 72, pages 4555 - 4558
    - CALDERHEAD ET AL., CURR. TOP. MICROBIOL. IMMUNOL., (2000), vol. 245, pages 73 - 99
 WO1986US02269
otherWO0139722
 EP1234031
 EP1210428
 EP1234031
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.